Patient info Search Menu

Sodium Citrate 0.3M oral solution – patient leaflet, side effects, dosage

Updated:
Key facts
Status:
Prescription only (POM)
Medicine strength:
88.23 mg/ml
Contains active substance:

Patient leaflet - Sodium Citrate 0.3M oral solution

1. What Sodium Citrate 0.3M Oral Solution is and what it is used for

Sodium Citrate 0.3M Oral Solution is used as an antacid prior to anaesthesia for caesarian section.

2. Before you take Sodium Citrate 0.3M Oral Solution

Do not take this medicine if you are allergic to sodium citrate or any of the other ingredients.

Sodium Citrate 0.3M Oral Solution is licensed for use by adults.

Tell your doctor or nurse if:

you suffer from aldosteronism, heart problems, kidney problems, high blood pressure, abnormally low levels of calcium in the blood or excessive accumulation of fluid in the body tissues (oedema)

or if:

you are taking other medication, in case this may be affected. Antacid treatments such as Sodium Citrate may affect the absorption or elimination of other medicines you may be taking.

3. How to take Sodium Citrate 0.3M Oral Solution

Your doctor or nurse will give you a whole container of Sodium Citrate 0.3M Oral Solution for you to drink.

If you take more than you should:

The main effects of overdose of sodium citrate are those of sodium overload. You will need special care until the levels of sodium can be brought down.

Please read all of this leaflet carefully before you take this medicine.

  • Keep this leaflet. You may need to read it again.
  • If you have further questions, please ask your doctor, pharmacist or qualified healthcare practitioner.

    Sodium Citrate 0.3M Oral Solution

    D05311 Patient Information Leaflet

    100mm Measurement Verification Bar 5311-C

4. Possible side effects

There are normally no side effects if Sodium Citrate 0.3M Oral Solution is given as directed, but if you do experience any side effects or think you may be reacting badly in any way, inform your doctor or nurse immediately.

5. How to store Sodium Citrate 0.3M Oral Solution

Keep out of the reach and sight of children.

Do not use Sodium Citrate 0.3M Oral Solution after the expiry date which is stated on the label. Your doctor or nurse will check this for you.

The containers should be stored at a temperature not above 25ºC and kept in the outer box.

6. Further information

What Sodium Citrate 0.3M Oral Solution contains:

The active ingredient is Sodium Citrate. Each bottle contains 2.647g of Sodium Citrate in 30 ml of Purified Water and Glycerol.

What this medicine looks like and contents of the pack

Sodium Citrate 0.3M Oral Solution is a clear liquid licensed to be available in 30 ml containers.

Marketing Authorisation Holder

Macarthys Laboratories limited

T/A Martindale Pharma,

Bampton Road,

Romford,

Essex,

RM3 8UG,

United Kingdom

Manufacturer

Queens Hospitals, Burton,

Pharmacy Manufacturing Unit, Queens Hospital, Belvedere Road, Burton-On-Trent, DE13 0RB, United Kingdom

Registration No: PL 01883/0343

This leaflet was revised in: April 2020

LEAF0020/03

D05311

5311-C 100mm Measurement Verification Bar

About this document

Source: MHRA - Medicines and Healthcare products Regulatory Agency (products.mhra.gov.uk)

Last revision stated in the text: April 2020

What the sections and the side effect frequencies mean: How to read a patient leaflet

Found a mistake? Tell us on the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Facts about Sodium Citrate 0.3M oral solution

What these facts mean

Prescription needed?? Yes, prescription-only medicine (POM)
Active substance? Sodium citrate
Strength? 88.23 mg/ml
Pharmaceutical form? Oral solution
The product is a clear and colourless solution.
How is it taken? Oral
Excipients? Purified water, Glycerol
Pack sizes 300 ml
Is it available?? Listed as available (NHS Dictionary of Medicines and Devices – not a record of current supplies)
Shelf life? 24 months
Storage Do not store above 25°C.
Store in the original bottle in order to protect from light. Keep the bottle tightly closed.
For single use only. Discard any remaining solution.
Marketing authorisation? PLGB 48259/0096 (first authorised 15 December 2022)
Marketing authorisation holder? Northumbria Pharma Ltd.
Codes? GTIN 5060618360748 · BNF 01010100

Sources: the MHRA product information (products.mhra.gov.uk) and the NHS Dictionary of Medicines and Devices (dm+d), release 11.1.0 of 9 November 2026, NHS Business Services Authority. Contains public sector information licensed under the Open Government Licence v3.0.